urogenital cancer
Showing 9976 - 10000 of >10,000
Infertility, Female, Female Infertility Trial in Taipei City (web-based decision aid)
Recruiting
- Infertility, Female
- Female Infertility
- web-based decision aid
-
Taipei City, Taipei, TaiwanNational Taiwan University Hospital
May 5, 2022
Breast Cancer, Breast Cancer Metastatic Trial in Spain (Niraparib 100 MG, Aromatase Inhibitors)
Terminated
- Breast Cancer
- Breast Cancer Metastatic
- Niraparib 100 MG
- Aromatase Inhibitors
-
A Coruña, Spain
- +9 more
Jan 17, 2023
Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal
Recruiting
- Gastric Cancer
- +2 more
- Establishment of organoid cultures and in vitro sensitivity testing
-
Dresden, Germany
- +1 more
Jan 11, 2023
Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3 Trial in Washington, Hackensack (NY-ESO-1 Peptide
Not yet recruiting
- Ovarian Cancer Stage IV
- +2 more
- NY-ESO-1 Peptide vaccine
- Nivolumab
-
Washington, District of Columbia
- +2 more
Jul 28, 2022
Prostate Cancer Trial in San Francisco (CTT1403, CTT1057, 68Ga-PSMA-11)
Active, not recruiting
- Prostate Cancer
- CTT1403
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Apr 14, 2022
Human Papilloma Virus, Cervical Intraepithelial Neoplasia, Cervical Cancer Trial in Lund, Stockholm (HPV testing)
Recruiting
- Human Papilloma Virus
- +2 more
- HPV testing
-
Lund, Skåne, Sweden
- +1 more
Apr 11, 2022
Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento
Recruiting
- Advanced Urothelial Carcinoma
- +3 more
- Pembrolizumab
- Selinexor
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Jun 28, 2022
Cancer of Prostate Trial in Ann Arbor (ADT ORDER CHECK ATTESTATION (OR), PROVIDER SCRIPT (SC))
Active, not recruiting
- Cancer of Prostate
- ADT ORDER CHECK ATTESTATION (OR)
- PROVIDER SCRIPT (SC)
-
Ann Arbor, MichiganVA Ann Arbor Healthcare System
Nov 7, 2022
Colorectal Cancer Trial in Hangzhou (Surufatinib, Toripalimab, chemo)
Recruiting
- Colorectal Cancer
- Surufatinib
- +2 more
-
Hangzhou, Zhejiang, ChinaFirst affiliated hospital, Zhejiang University
Feb 26, 2022
Metastatic Pancreatic Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)
Completed
- Metastatic Pancreatic Cancer
- Ad5-yCD/mutTKSR39rep-hIL12
-
Detroit, MichiganHenry Ford Hospital
Feb 15, 2022
Virtual Reality, Pediatrics, Cancer Trial in Poitiers (Virtual Reality, Usual Practices)
Recruiting
- Virtual Reality
- +4 more
- Virtual Reality
- Usual Practices
-
Poitiers, FranceCHU poitiers
Nov 30, 2022
Stomatitis, Oral Mucositis, Tumor of the Breast Trial in US (Miracle Mouthwash Plus Hydrocortisone, Prednisolone)
Completed
- Stomatitis
- +3 more
- Miracle Mouthwash Plus Hydrocortisone
- Prednisolone
-
US, Texas12 sites incl Yakima, WA, Boulder, CO, and Austin, TX
Nov 29, 2022
Pancreas Cancer Trial in Baltimore (Biofeedback, Active Breathing Control Technique)
Recruiting
- Pancreas Cancer
- Biofeedback
- Active Breathing Control Technique
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 1, 2022
Prostate Cancer, Prostate Cancer Recurrent Trial in Mineola (Metformin Hydrochloride Extended Release 750mg)
Completed
- Prostate Cancer
- Prostate Cancer Recurrent
- Metformin Hydrochloride Extended Release 750mg
-
Mineola, New YorkWinthrop University Hospital
Feb 2, 2022
Adherence, Gastrointestinal Cancer Trial in Loures (Combined Exercise and Dietary Intervention (CEDI), Standard Care)
Recruiting
- Adherence
- Gastrointestinal Cancer
- Combined Exercise and Dietary Intervention (CEDI)
- Standard Care
-
Loures, Lisboa, PortugalHospital Beatriz Ângelo
Feb 9, 2022
Head Neck Cancer, Head and Neck Tumors, Surgery Trial in Calgary (Prehabilitation)
Recruiting
- Head and Neck Cancer
- +2 more
- Prehabilitation
-
Calgary, Alberta, CanadaUniversity of Calgary
Feb 18, 2022
Esophagus Cancer, Esophageal Cancer, Cancer of the Esophagus Trial in Saint Louis (Proton beam therapy, Patient-Reported Outcome
Active, not recruiting
- Esophagus Cancer
- +2 more
- Proton beam therapy
- Patient-Reported Outcome Measures
-
Saint Louis, MissouriWashington University School of Medicine
Aug 10, 2022
Triple Negative Breast Cancer, PD-L1 Negative Trial in Puerto Rico, United States (Sacituzumab Govitecan-hziy, Paclitaxel,
Recruiting
- Triple Negative Breast Cancer
- PD-L1 Negative
- Sacituzumab Govitecan-hziy
- +4 more
-
Anchorage, Alaska
- +231 more
Jan 17, 2023
Solid Tumor, Non Small Cell Lung Cancer, Pancreatic Cancer Trial in Israel, United States (CM-24 and Nivolumab - Dose
Recruiting
- Solid Tumor
- +6 more
- CM-24 and Nivolumab - Dose Escalation
- +4 more
-
Scottsdale, Arizona
- +10 more
Jan 17, 2023
NSCLC Stage IV, EGFR Gene Mutation Trial in Worldwide (Osimertinib, Stereotactic Body Radiation Therapy (SBRT))
Recruiting
- NSCLC Stage IV
- EGFR Gene Mutation
- Osimertinib
- Stereotactic Body Radiation Therapy (SBRT)
-
Alessandria, Italy
- +15 more
Mar 29, 2022
Prostate Cancer Trial in Hong Kong (Cryotherapy)
Recruiting
- Prostate Cancer
- Cryotherapy
-
Hong Kong, Hong KongPrince of Wales Hospital, Chinese University of Hong Kong
Dec 30, 2021
Pancreatic Cancer Trial in Boston, Philadelphia (Gemcitabine, Nab-paclitaxel, Paricalcitol)
Active, not recruiting
- Pancreatic Cancer
- Gemcitabine
- +3 more
-
Boston, Massachusetts
- +1 more
Jan 9, 2023
Breast Cancer Female Trial in London (Intraoperative CLI + FAR LightPath imaging)
Not yet recruiting
- Breast Cancer Female
- Intraoperative CLI + FAR LightPath imaging
-
London, United KingdomGuy's and St Thomas NHS Trust
Aug 9, 2022